Singapore markets close in 1 hour 14 minutes
Straits Times Index
3,266.31 +41.14 (+1.28%) Nikkei
37,552.16 +113.55 (+0.30%) Hang Seng
16,825.56 +313.87 (+1.90%) FTSE 100
8,060.26 +36.39 (+0.45%) Bitcoin USD
66,187.99 +76.85 (+0.12%) CMC Crypto 200
1,396.69 -18.06 (-1.28%)
Inovio Pharmaceuticals, Inc. (INO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 259.07M |
| Enterprise value | 143.98M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 266.51 |
| Price/book (mrq) | 2.21 |
| Enterprise value/revenue | 173.05 |
| Enterprise value/EBITDA | -1.10 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.12 |
| 52-week change 3 | 1.83% |
| S&P500 52-week change 3 | 23.06% |
| 52-week high 3 | 14.75 |
| 52-week low 3 | 3.84 |
| 50-day moving average 3 | 10.21 |
| 200-day moving average 3 | 6.74 |
Share statistics
| Avg vol (3-month) 3 | 496.89k |
| Avg vol (10-day) 3 | 381.21k |
| Shares outstanding 5 | 25.91M |
| Implied shares outstanding 6 | 25.91M |
| Float 8 | 23.03M |
| % held by insiders 1 | 1.48% |
| % held by institutions 1 | 16.66% |
| Shares short (28 Mar 2024) 4 | 2.1M |
| Short ratio (28 Mar 2024) 4 | 3.53 |
| Short % of float (28 Mar 2024) 4 | 9.06% |
| Short % of shares outstanding (28 Mar 2024) 4 | 9.00% |
| Shares short (prior month 29 Feb 2024) 4 | 1.86M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:12 |
| Last split date 3 | 25 Jan 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -26,686.29% |
Management effectiveness
| Return on assets (ttm) | -32.11% |
| Return on equity (ttm) | -79.55% |
Income statement
| Revenue (ttm) | 832.01k |
| Revenue per share (ttm) | 0.04 |
| Quarterly revenue growth (yoy) | -17.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -130.66M |
| Net income avi to common (ttm) | -135.12M |
| Diluted EPS (ttm) | -6.09 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 145.29M |
| Total cash per share (mrq) | 6.22 |
| Total debt (mrq) | 30.21M |
| Total debt/equity (mrq) | 25.74% |
| Current ratio (mrq) | 3.60 |
| Book value per share (mrq) | 5.15 |
Cash flow statement
| Operating cash flow (ttm) | -124.37M |
| Levered free cash flow (ttm) | -86.15M |
© 2024 Yahoo. All rights reserved.